PATENT CLAIM ANALYSIS

Application Number: 16382907
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "259300"]

Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

Claim (Index 52):
The method of  claim 51  wherein the inflammatory disorder is selected from rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, psoriasis, Crohn's disease, ulcerative colitis, and inflammatory bowel disease.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 100.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16382824', '16382869', '16382680', '15097402', '14634041']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.855021649345236
- 35 USC 102 Novelty (BERT): 0.5434535677590097
- Combined Prediction Score: 0.8238648411866134
- Mean Citation Score: 418.320736
- Max Citation Score: 433.35553
- Similarity Product: 231.67879720956324

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test